Early lupus patient data sends Kezar Life Sciences' stock soaring after-hours
June 27, 2022 at 21:31 PM EDT
The company's stock also took a substantial dive early last month after the same drug missed its mark in two other diseases.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|